Insights into the workings of an immune cell surface receptor, called PD-1, reveal how treatments that restrict its action can potentially be strengthened to improve their anticancer effect, a new study shows. The same findings ...
Mar 8, 2024
0
29
A University of Colorado Department of Medicine faculty member says she and her colleagues have identified the means in which bacteria in the digestive system can break down tryptophan in the diet into an inflammatory chemical ...
Mar 8, 2024
0
28
Combined, infection, autoimmunity and cancer account for 4 out of every 10 deaths worldwide, and represent major global health challenges. In a paper in the journal Cell Reports, Institute for Systems Biology (ISB) researchers ...
Mar 4, 2024
0
121
People who have had a kidney transplant are at high risk for developing skin cancers. New research directed by investigators from the Johns Hopkins Kimmel Cancer Center is exploring the best combination of treatments to target ...
Feb 28, 2024
0
0
If you've been bit by a stomach bug lately, you're not alone. The Centers for Disease Control and Prevention (CDC) is reporting significant norovirus activity across the country, especially in the West and Northeast.
Feb 27, 2024
0
0
A recent study investigated the correlation between the specific anti-spike SARS-CoV-2 IgG immune response resulting from vaccination or previous infection, viral load, and fecal virus excretion, as well as their impact on ...
Feb 26, 2024
0
1
In experiments with lab-grown brain cells and mouse models, scientists at Johns Hopkins Medicine say they have discovered that a cell surface protein called Lag3 is not only a biological target for FDA-approved drugs that ...
Feb 23, 2024
0
90
A research project supported by the National Institutes of Health has developed a tool to rapidly and inexpensively diagnose sarcoidosis, a chronic inflammatory disease marked by the growth of tiny lumps called granulomas ...
Feb 22, 2024
0
0
What initially was referred to as "Paxlovid rebound"—a return of COVID symptoms or test positivity after starting a course of the antiviral—is now more accurately referred to as "COVID rebound," because rebound can happen ...
Feb 21, 2024
0
1
Immune cells must learn not to attack the body itself. A team of researchers from the Technical University of Munich (TUM) and the Ludwig Maximilian University of Munich (LMU) has discovered a previously unknown mechanism ...
Feb 21, 2024
1
51
